Drug Trial Radar · NCT01674530
Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation
Last checked: Nov 19, 2026Latest source record: Apr 3, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
909
Actual
Start
Oct 2012
Primary completion
Jan 2014
Study completion Mar 2014
Sponsor
- Lead sponsor
- Dr. Reddy's Laboratories Limited, IndiaIndustry
- Sponsor type
- Industry
- Collaborators
- Parexel
- First posted
- Aug 29, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the clinical equivalence and safety of the test formulation of Lubiprostone 24 mcg capsules manufactured by Dr Reddy's Laboratories Ltd compared to the marketed formulation AMITIZA® ( Lubiprostone) 24 mcg capsules (Sucampo Pharmaceuticals, Inc.) in patients with confirmed Chronic Idiopathic Constipation
Conditions
- Chronic Idiopathic Constipation
Interventions
LubiprostoneDrug
24 mcg Capsules to be given in the experimental arm with Placebo Of AMITIZA
LubiprostoneDrug
24 mcg Capsules with placebo of Lubiprostone ( Manufactured by Dr Reddy's Laboratories Ltd)
PlaceboDrug
24 mcg capsules of both experimental Lubiprostone and AMITIZA
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary AnalysisTime frame: Day 8
Locations
93 sites in 1 country. Site status is shown where the registry gives one.
Radiant Research
Birmingham, Alabama
Digestive Health Specialists of the Southeast
Dothan, Alabama
Clinical Research Associates
Huntsville, Alabama
Drug Research Group, LLC
Mobile, Alabama
Radiant Research
Scottsdale, Arizona
Adobe Clinical Research , LLC
Tucson, Arizona
Visions Clinical Research
Tucson, Arizona
SC Clinical Research, Inc
Tucson, Arizona
Preferred Research Partners
Little Rock, Arkansas
Anaheim Clinical Trials
Anaheim, California
Diagnamics Inc,477 N. El Camino Real,Suite A100
Encinitas, California
Advanced Medical Research Institute
Fresno, California
Research Center of Fresno
Fresno, California
Translational Research Group
North Hollywood, California
Staywell Research
Northridge, California
Elias Research Associates
Orange, California
Benchmark Research
Sacramento, California
Medical Center for CR
San Diego, California
Shawn K Hassler
San Francisco, California
SC Clinical Research, Inc ,1060 E. Foothill Blvd, Suite 204
Upland, California
Progressive Clinical Research
Vista, California
Horizons Clinical Research Center
Denver, Colorado
Radiant Research
Denver, Colorado
Lynn Institute of Denver
Denver, Colorado
Consultants of Clinical
Boynton Beach, Florida
PAB Clinical Research
Brandon, Florida
Elite Trials
Clearwater, Florida
Health Care Family Rehabilitation and Research Center
Hialeah, Florida
Medical Research Unlimited, LLC
Hialeah, Florida
Health Awareness ,Inc
Jupiter, Florida
Sunrise Medical Research
Lauderdale Lakes, Florida
San Marcus Research Clinic
Miami, Florida
Pharmax Research Clinic
Miami, Florida
Community Research Foundation , Inc.
Miami, Florida
Florida International Research
Miami, Florida
Columbus Clinical Services
Miami, Florida
South Medical Research Group , Inc
Miami, Florida
Pharma Research International, Inc
Naples, Florida
Pharma Research International, Inc
Naples, Florida
Compass Research
Orlando, Florida
Showing 40 of 93 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.